BackChina Jo-Jo Drugstores Overview

China Jo-Jo Drugstores Total Current Liabilities

China Jo-Jo Drugstores's total current liabilities is $68M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$67.54M
3.22% YoYΔ $-2.25M vs prior year quarter

Peer average

Loading

China Jo-Jo Drugstores Total Current Liabilities History

Loading

China Jo-Jo Drugstores vs. peers: Total Current Liabilities Comparison

Loading

China Jo-Jo Drugstores Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

China Jo-Jo Drugstores (CJJD) FAQ

The latest total current liabilities for CJJD is $68M as of September 2024. That compares with $70M in the prior-year period — down 3.2% year over year. Investors often review this figure alongside China Jo-Jo Drugstores's historical trend and sector peers before judging valuation or financial health.

Over the past year, CJJD's total current liabilities moved from $70M to $68M — a 3.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in China Jo-Jo Drugstores's operating scale or balance-sheet position.

A total current liabilities figure of $68M for CJJD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CJJD's total current liabilities ($68M), review year-over-year change from $70M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack China Jo-Jo Drugstores's total current liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.